Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Michael H. Le, David Le, Thomas C. Baez, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 2, pp. 235-246
Open Access | Times Cited: 24

Showing 24 citing articles:

Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions
Lung‐Yi Mak, Ken Liu, Sakkarin Chirapongsathorn, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 12, pp. 834-851
Closed Access | Times Cited: 20
Metabolic Dysfunction-Associated Steatotic Liver Disease and the Cardiovascular System
Antonis A. Manolis, Theodora A. Manolis, Apostolos Vouliotis, et al.
Trends in Cardiovascular Medicine (2025)
Closed Access | Times Cited: 4
Correlation between metabolic dysfunction-associated steatotic liver disease and subclinical coronary atherosclerosis in eastern China
Guanghui Ma, Guohou Xu, Haixia Huang
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
A Novel Point-of-Care Prediction Model for Steatotic Liver Disease: Expected Role of Mass Screening in the Global Obesity Crisis
Jeayeon Park, Goh Eun Chung, Yoosoo Chang, et al.
Gut and Liver (2025)
Open Access
Association Between Handgrip Strength and Cardiovascular Disease Risk in MASLD: A Prospective Study From UK Biobank
Tae Seop Lim, Sujin Kwon, Sung A. Bae, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 2
Open Access
Underrepresentation of Asians in diagnostic test development and drug trials in MASLD
Lung‐Yi Mak, Terry Cheuk‐Fung Yip, Chi‐Ho Lee, et al.
Journal of Hepatology (2025)
Closed Access
An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, et al.
Metabolism (2024), pp. 156080-156080
Open Access | Times Cited: 4
Correspondence on Letter regarding “Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study”
Hideki Fujii, Michihiro Iwaki, Yoshihiro Kamada
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 2, pp. 281-283
Open Access | Times Cited: 3
Steatotic liver disease: Know your enemies
Lung‐Yi Mak
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 2, pp. 171-173
Open Access | Times Cited: 3
Equivalent prevalence and progression of chronic kidney disease in non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 962-964
Open Access | Times Cited: 3
Inducible nitric oxide synthase accelerates nonalcoholic fatty liver disease progression by regulating macrophage autophagy
Guiyuan Jin, Xiaoying Yao, Dong Liu, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 12
Open Access | Times Cited: 8
An analysis of the burden of liver cirrhosis: Differences between the global, China, the United States and India
Keqiang Lu, Juanjuan Sui, Wenhui Yu, et al.
Liver International (2024)
Closed Access | Times Cited: 2
Evolving epidemiology of NAFLD in South Korea: incidence, prevalence, progression, and healthcare implications from 2010 to 2022
Jae Woo Park, Jeong‐Ju Yoo, Dong Hyeon Lee, et al.
The Korean Journal of Internal Medicine (2024) Vol. 39, Iss. 6, pp. 931-944
Open Access | Times Cited: 2
Polyphenols and terpenoids derived from Ocimum species as prospective hepatoprotective drug leads: a comprehensive mechanistic review
Amrita Chatterjee, Biswatrish Sarkar
Phytochemistry Reviews (2024)
Closed Access | Times Cited: 1
PAMK Ameliorates Non-Alcoholic Steatohepatitis and Associated Anxiety/Depression-like Behaviors Through Restoring Gut Microbiota and Metabolites in Mice
Jianmei Yang, Wanyi Ou, Guiru Lin, et al.
Nutrients (2024) Vol. 16, Iss. 22, pp. 3837-3837
Open Access | Times Cited: 1
In response to: Steatotic liver disease-know your enemies
Michael H. Le, Linda Henry, Mindie H. Nguyen
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 2, pp. 284-286
Open Access
Treatment of Metabolic Disorders Using Novel DGAT2 Inhibitors: Pyrazolopyridine and Triazolopyridine Derivatives
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1199-1200
Open Access
Fatty acid composition of blood serum and erythrocyte membranes in men with steatosis and steatohepatitis with normal transaminase activity
М. В. Кручинина, М. Ф. Осипенко, Alexander A. Shestov, et al.
Sechenov Medical Journal (2024) Vol. 15, Iss. 2, pp. 48-60
Open Access
The Predictive Value of Time‐Varying Noninvasive Scores on Long‐Term Prognosis of NAFLD in South Korea
Sung Won Chung, Min Kyung Park, Xiao Zhang, et al.
Canadian Journal of Gastroenterology and Hepatology (2024) Vol. 2024, Iss. 1
Open Access
Pathogenesis and management of metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma: a narrative review
Han Ah Lee
The Ewha Medical Journal (2024) Vol. 47, Iss. 4
Open Access
All-Cause and Disease-Specific Mortality in Young Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Cohort Study
Jeayeon Park, Goh Eun Chung, Su Jong Yu, et al.
(2024)
Closed Access
Association between skeletal muscle mass to visceral fat area ratio and depression: A cross-sectional study based on the National Health and Nutrition Examination Survey
Chenle Ye, Guangzhan Chen, Wei‐Kai Huang, et al.
Journal of Affective Disorders (2024) Vol. 372, pp. 314-323
Closed Access
Type 2 diabetes and the minor allele of PNPLA3 consistently identify high-risk metabolic dysfunction associated steatotic liver disease
Zobair M. Younossi, J. Michael Estep, Sean Felix, et al.
Diabetes Research and Clinical Practice (2024), pp. 111960-111960
Closed Access
Acetaminophen protein adduct concentrations during therapeutic dosing in patients with class II-III obesity compared to non-obese and overweight patients: a prospective observational gender stratified cohort study
H.A. De Baerdemaeker, Paul De Cock, Luc De Baerdemaeker
Acta Anaesthesiologica Belgica (2024) Vol. 75, Iss. Supplement 1, pp. 63-74
Closed Access
Page 1

Scroll to top